Geology ReportsSearch

USGS · 70221846

Sarcoptic mange: An emerging panzootic in wildlife

Abstract

Sarcoptic mange, a skin infestation caused by the mite Sarcoptes scabiei , is an emerging disease for some species of wildlife, potentially jeopardizing their welfare and conservation. Sarcoptes scabiei has a near-global distribution facilitated by its forms of transmission and use of a large diversity of host species (many of those with broad geographic distribution). In this review, we synthesize the current knowledge concerning the geographic and host taxonomic distribution of mange in wildlife, the epidemiological connections between species, and the potential threat of sarcoptic mange for wildlife conservation. Recent sarcoptic mange outbreaks in wildlife appear to demonstrate ongoing geographic spread, increase in the number of hosts and increased virulence. Sarcoptic mange has been reported in at least 12 orders, 39 families and 148 species of domestic and wild mammals, making it one of the most generalist ectoparasites of mammals. Taxonomically, the orders with most species found infested so far include Perissodactyla (67% species from the entire order), Artiodactyla (47%), and Diprotodontia (67% from this order). This suggests that new species from these mammal orders are likely to suffer cross-species transmission and be reported positive to sarcoptic mange as surveillance improves. We propose a new agenda for the study of sarcoptic mange in wildlife, including the study of the global phylogeography of S. scabiei , linkages between ecological host traits and sarcoptic mange susceptibility, immunology of individuals and species, development of control strategies in wildlife outbreaks and the effects of global environmental change in the sarcoptic mange system. The ongoing transmission globally and sustained spread among areas and wildlife species make sarcoptic mange an emerging panzootic in wildlife. A better understanding of sarcoptic mange could illuminate the aspects of ecological and evolutionary drivers in cross-species transmission for many emerging diseases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L. E. Escobar, Scott Carver, Paul C. Cross, Luca Rossi, E. S. Almberg, M. J. Yabsley, K D Niedringhaus, Peach Van Wick, Ernesto Dominguez-Villegas, F.F. Gakuya, Yue Xie, Samer Angelone, Christian Gortazar, Francisca Astorga. 2021-05-02. Sarcoptic mange: An emerging panzootic in wildlife. https://doi.org/10.1111/tbed.14082

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related USGS reports

Rapid risk assessment framework to estimate potential for spillback at human-wildlife interfaces

More than 60% of emerging infectious diseases of humans have a wildlife origin, and when these diseases spread through human populations to new geographical areas, there is a considerable risk of spillback from humans to wildlife species. Spillback events can have severe consequences for wildlife populations, where the disease may cause morbidity and mortality, and human populations, where the establishment in wildlife may lead to prolonged transmission or new exposures in humans. Mitigating these consequences requires identifying the key risk factors that lead to human–wildlife transmission events and implementing risk-reducing actions, a challenge given that cross-species transmission events are rare and often data deficient. To identify potential species and locations that are most likely to lead to these rare events, we developed a spatially explicit, rapid risk assessment framework that incorporates three components of the spillback process: wildlife susceptibility, wildlife exposure, and pathogen introduction pressure. To demonstrate the broad applicability of our framework, we conducted a rapid risk assessment on two recent emerging zoonotic pathogens in humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and mpox, to determine the relative spillback risk to wild mammalian species in the continental United States. The rapid risk assessment identified both species and locations with higher than expected spillback risk, providing managers and researchers with valuable information to prioritize surveillance and risk-mitigation actions. Our framework represents a rapid and flexible approach to assess the risks of spillback to wildlife populations during rapidly evolving zoonotic disease outbreaks.

Transboundary and Emerging Diseases

Fomites could determine severity of SARS-CoV-2 outbreaks in low-density white-tailed deer (Odocoileus virginianus) populations

The establishment of a reservoir species for zoonotic diseases is concerning for both animal and human health. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2, the coronavirus responsible for the COVID-19 pandemic, has been detected in white-tailed deer ( Odocoileus virginianus ) in the United States. Since its initial detection, various studies have documented circulation and evolution of SARS-CoV-2 in deer, with human cases suspected of spill-back from infectious deer. A priority for mitigating SARS-CoV-2 outbreaks in deer populations is determining the contribution of direct (via aerosols and physical contact) and indirect (via contaminated objects and media) transmission pathways. We expanded existing epidemiological models founded on direct transmission pathways to include three indirect transmission pathways of infection for simulated deer populations, including contaminated water, food waste, and feed piles. Despite lower infection probabilities and transmission hazards (measured by force-of-infection (FOI)) posed solely by these indirect pathways compared to direct transmission pathways, the addition of indirect transmission pathways increased FOI, which had ramifications for the severity of SARS-CoV-2 outbreaks in simulated deer populations, particularly in populations with low degrees of spread between deer (measured by basic reproductive number; R 0 ). We used contact rate models to estimate SARS-CoV-2 spread across deer range in the United States and identified widespread potential for indirect transmission to increase the severity of outbreaks in low-density deer populations. These results indicate that indirect transmission pathways need to be considered in the management of white-tailed deer as a reservoir species for SARS-CoV-2.

Transboundary and Emerging Diseases

Detection of tick-borne pathogen coinfections and coexposures to foot-and-mouth disease, brucellosis, and Q fever in selected wildlife from Kruger National Park, South Africa, and Etosha National Park, Namibia

Background: Although the rate of emerging infectious diseases that originate in wildlife has been increasing globally in recent decades, there is currently a lack of epidemiological data from wild animals. Methodology: We used serology to determine prior exposure to foot-and-mouth disease virus (FMDV), Brucella spp., and Coxiella burnetii and used genetic testing to detect blood-borne parasitic infections in the genera Ehrlichia , Anaplasma , Theileria , and Babesia from wildlife in two national parks, Kruger National Park (KNP), South Africa, and Etosha National Park (ENP), Namibia. Serum and whole blood samples were obtained from free-roaming plains zebra ( Equus quagga ), greater kudu ( Tragelaphus strepsiceros ), impala ( Aepyceros melampus ), and blue wildebeest ( Connochaetes taurinus ). Risk factors (host species, sex, and sampling park) for infection with each pathogen were assessed, as well as the prevalence and distribution of co-occurring infections. Results: In KNP 13/29 (45%; confidence interval [CI]: 26%–64%) kudus tested positive for FMD, but none of these reacted to SAT serotypes. For brucellosis, seropositive results were obtained for 3/29 (10%; CI: 2%–27%) kudu samples. Antibodies against C. burnetii were detected in 6/29 (21%; CI: 8%–40%) kudus, 14/21 (67%; CI: 43%–85%) impalas, and 18/39 (46%; CI: 30%–63%) zebras. A total of 28/28 kudus tested positive for Theileria spp. (100%; CI: 88%–100%) and 27/28 for Anaplasma/Ehrlichia spp. (96%; CI: 82%–100%), whereas 12/19 impalas (63%) and 2/39 zebra (5%) tested positive for Anaplasma centrale . In ENP, only 1/29 (3%; CI: 0%–18%) wildebeest samples tested positive for FMD. None of the samples tested positive for brucellosis, while C. burnetii antibodies were detected in 26/30 wildebeests (87%; CI: 69%–96%), 16/40 kudus (40%; CI: 25%–57%), and 26/26 plains zebras (100%; CI: 87%–100%). A total of 60% Anaplasma/Ehrlichia spp. and 35% Theileria/Babesia spp. in kudu and 37% wildebeest tested positive to Theileria sp. (sable), 30% to Babesia occultans , and 3%–7% to Anaplasma spp. The seroprevalence of Q fever was significantly higher in ENP, while Brucella spp., Anaplasma , Ehrlichia , Theileria , and Babesia species were significantly higher in KNP. Significant coinfections were also identified. Conclusion: This work provided baseline serological and molecular data on 40+ pathogens in four wildlife species from two national parks in southern Africa.

Etosha National Park, Kruger National Park